To achieve capital growth through investing in high growth, development stage biotechnology companies.
Find out MoreInt.biotech. Share Price | |
---|---|
Price | 627.00 |
Bid | 622.00 |
Ask | 628.00 |
Change | 0.00 (0.00%) |
Volume | 12,709 |
Open | 627.00 |
High | 0.00 |
Low | 0.00 |
Prev. Close | 627.00 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 37.77m |
Market Capitalisation | £236.80m |
Market Size | 750 |
52 Week High | 704.00 |
52 Week High Date | 28-Feb-2024 |
52 Week Low | 548.00 |
52 Week Low Date | 27-Oct-2023 |
# Trades | 18 |
---|---|
Vol. Sold | 9,704 |
Sold Value | £60.69k |
Vol. Bought | 3,005 |
Bought Value | £18.90k |
PE Ratio | 37.34366 |
Earnings | 16.79 |
Dividend | 28.20 |
Yield | 4.498% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
24-Apr-24 | 12:56:28 | 628.813 | 225 | Buy* | 620.00 | 634.00 | 1,415 | O Ordinary |
24-Apr-24 | 12:44:35 | 626.014 | 810 | Sell* | 620.00 | 634.00 | 5,071 | O Ordinary |
24-Apr-24 | 12:44:25 | 628.813 | 810 | Buy* | 620.00 | 634.00 | 5,093 | O Ordinary |
24-Apr-24 | 12:19:18 | 628.806 | 175 | Buy* | 620.00 | 634.00 | 1,100 | O Ordinary |
24-Apr-24 | 11:46:41 | 626.00 | 1,000 | Sell* | 620.00 | 634.00 | 6,260 | O Ordinary |
24-Apr-24 | 11:46:33 | 628.82 | 1,000 | Buy* | 620.00 | 634.00 | 6,288 | O Ordinary |
24-Apr-24 | 11:39:46 | 626.00 | 321 | Sell* | 620.00 | 634.00 | 2,009 | O Ordinary |
24-Apr-24 | 11:37:10 | 626.00 | 650 | Sell* | 620.00 | 634.00 | 4,069 | O Ordinary |
24-Apr-24 | 11:33:14 | 626.00 | 1,302 | Sell* | 620.00 | 634.00 | 8,151 | O Ordinary |
24-Apr-24 | 10:53:46 | 634.00 | 1 | Buy* | 620.00 | 634.00 | 6.34 | O Ordinary Trade was executed as an SI |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
07-Nov-23 | 07-Nov-23 | Buy | Caroline Gulliver held the position of Independent Non-Executive Director at the time of this trade.Caroline Gulliver | 573.15 | GBX | 2,500 | 17,000 |
04-Aug-23 | 03-Aug-23 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 632.00 | GBX | 1,500 | 11,500 |
03-Aug-23 | 03-Aug-23 | Buy | Katherine Cornish-Bowden held the position of Senior Independent Director at the time of this trade.Katherine Cornish-Bowden | 633.18 | GBX | 1,500 | 12,500 |
11-May-22 | 11-May-22 | Buy | Patrick Maxwell held the position of Independent Non-Executive Director at the time of this trade.Patrick Maxwell | 589.35 | GBX | 3,725 | 3,725 |
01-Apr-22 | 01-Apr-22 | Buy | Patrick Magee held the position of Independent Non-Executive Director at the time of this trade.Patrick Magee | 633.00 | GBX | 2,500 | 10,000 |